Fisher & Paykel Healthcare Executive Increases Shareholding via Employee Plan

The latest announcement is out from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ).

Fisher & Paykel Healthcare has disclosed that Justin Peter Callahan, its Vice President of Sales & Marketing, has increased his beneficial holding of ordinary shares through participation in the company’s Employee Stock Purchase Plan. Callahan purchased 129 ordinary shares at NZD 31.2811 each on 1 April 2026, lifting his total direct shareholding to 220,867 shares and underscoring continued executive alignment with shareholder interests.

In addition to his ordinary shareholding, Callahan holds 103,960 options to acquire ordinary shares and 64,091 performance share rights, further tying his remuneration to the company’s long-term performance. The disclosure, made under New Zealand’s Financial Markets Conduct Act, provides transparency for investors regarding insider holdings and reinforces governance standards around executive equity participation.

More about Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical technology company that designs, manufactures, and markets respiratory care and acute care products. Its primary offerings include hospital and homecare respiratory devices, with a market focus on improving patient care in critical and chronic respiratory conditions globally.

For a thorough assessment of FSPKF stock, go to TipRanks’ Stock Analysis page.